MMSL 2024, 93(2):218-223 | DOI: 10.31482/mmsl.2023.021

RESISTIN IN RHEUMATOID ARTHRITISReview article

Fatimah Haitham Fathi ORCID...1*, Ammar A.Y. Almulathanon ORCID...2, Jehan A. Mohammad ORCID...3
1 Department of Clinical Laboratory Sciences, College of Pharmacy, University of Mosul, Mosul, Iraq
2 Department of Pharmacology and Toxicology, College of Pharmacy, University of Mosul, Mosul, Iraq
3 Department of Pharmacognosy and Medicinal Plants, College of Pharmacy, University of Mosul, Mosul, Iraq

Rheumatoid arthritis (RA) is a chronic multisystem illness that affects millions of individuals. The primary goal of RA therapy is to improve patients' quality of life by reducing pain severity, preserving or improving functional capability, and decreasing disability. The significance of resistin in the pathophysiology of RA has been explored in recent years, although its role is unclear as it is largely produced by macrophages. In this review, we have analyzed 10 studies from the PubMed site that demonstrate a relationship between resistin levels and the severity of RA.

Keywords: Resistin; Rheumatoid arthritis, Adipokines, Cytokines and sverity of disease

Received: December 19, 2022; Revised: May 12, 2023; Accepted: May 12, 2023; Prepublished online: May 17, 2023; Published: June 3, 2024  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Fathi, F.H., Almulathanon, A.A.Y., & Mohammad, J.A. (2024). RESISTIN IN RHEUMATOID ARTHRITIS. MMSL, 93(2), 218-223. doi: 10.31482/mmsl.2023.021
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Mateen S, Zafar A, Moin S, et al. Understanding the role of cytokines in the pathogenesis of rheumatoid arthritis. Clin Chim Acta. 2016;455:161-171. Go to original source... Go to PubMed...
    2. Guidelines for the management of rheumatoid arthritis: 2002 Update. Arthritis Rheum. 2002;46(2):328-346. Go to original source... Go to PubMed...
    3. Barbosa V, Rêgo J, Antônio N. Possible role of adipokines in systemic lupus erythematosus and rheumatoid arthritis. Rev Bras Reumatol. 2012;52(2):278-287. Go to original source... Go to PubMed...
    4. Hutcheson J. Adipokines influence the inflammatory balance in autoimmunity. Cytokine. 2015;75(2):272-279. Go to original source... Go to PubMed...
    5. Zainab H. Fathi, Jehan A. Mohammad, et al. Evaluation of the Vasoprotective Effects of Metformin versus Glibenclamide in Type 2 Diabetic Patients. Research Journal of Pharmacy and Technology. 2021;14(12):6409-6412. Go to original source...
    6. McInnes IB, Liew FY. Cytokine networks--towards new therapies for rheumatoid arthritis. Nat Clin Pract Rheumatol. 2005;1(1):31-39. Go to original source... Go to PubMed...
    7. Bingham CO, 3rd. The pathogenesis of rheumatoid arthritis: pivotal cytokines involved in bone degradation and inflammation. J Rheumatol Suppl. 2002;65:3-9. Go to PubMed...
    8. Asquith DL, McInnes IB. Emerging cytokine targets in rheumatoid arthritis. Curr Opin Rheumatol. 2007;19(3):246-251. Go to original source... Go to PubMed...
    9. Williams RO, Paleolog E, Feldmann M. Cytokine inhibitors in rheumatoid arthritis and other autoimmune diseases. Curr Opin Pharmacol. 2007;7(4):412-417. Go to original source... Go to PubMed...
    10. Mohammed M, Mohammad J, Fathi Z, et al. Comparative evaluation of cystatin C and neutrophil gelatinase-associated lipocalin in patients with thalassemia major versus thalassemia intermedia. Pharmacia. 2021;68(4):741-746. Go to original source...
    11. Mohammad JA, Almulathanon AAY, Fathi FH. Assessment of the effects of metformin and glibenclamide on the concentration of selected trace elements in type 2 diabetic patients. Pharmacia. 2021;68(4). Go to original source...
    12. Gómez R, Conde J, Scotece M, et al. What's new in our understanding of the role of adipokines in rheumatic diseases? Nat Rev Rheumatol. 2011;7(9):528-536. Go to original source... Go to PubMed...
    13. Steppan CM, Bailey ST, Bhat S, et al. The hormone resistin links obesity to diabetes. Nature. 2001;409(6818):307-312. Go to original source... Go to PubMed...
    14. Lee JH, Chan JL, Yiannakouris N, et al. Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: cross-sectional and interventional studies in normal, insulin-resistant, and diabetic subjects. J Clin Endocrinol Metab. 2003;88(10):4848-4856. Go to original source... Go to PubMed...
    15. Codoñer-Franch P, Alonso-Iglesias E. Resistin: insulin resistance to malignancy. Clin Chim Acta. 2015;438:46-54. Go to original source... Go to PubMed...
    16. Abella V, Scotece M, Conde J, et al. Adipokines, metabolic syndrome and rheumatic diseases. Journal of immunology research. 2014;2014:343746. Go to original source... Go to PubMed...
    17. Kassem E, Sayed Ahmed L, et al. Study of Resistin and YKL-40 in Rheumatoid Arthritis. 2009.
    18. Kontunen P, Vuolteenaho K, Nieminen R, et al. Resistin is linked to inflammation, and leptin to metabolic syndrome, in women with inflammatory arthritis. Scand J Rheumatol. 2011;40(4):256-262. Go to original source... Go to PubMed...
    19. Fadda SM, Gamal SM, Elsaid NY, et al. Resistin in inflammatory and degenerative rheumatologic diseases. Relationship between resistin and rheumatoid arthritis disease progression. Z Rheumatol. 2013;72(6):594-600. Go to original source... Go to PubMed...
    20. Kang Y, Park HJ, Kang MI, et al. Adipokines, inflammation, insulin resistance, and carotid atherosclerosis in patients with rheumatoid arthritis. Arthritis Res Ther. 2013;15(6):R194. Go to original source... Go to PubMed...
    21. Bustos Rivera-Bahena C, Xibillé-Friedmann DX, González-Christen J, et al. Peripheral blood leptin and resistin levels as clinical activity biomarkers in Mexican Rheumatoid Arthritis patients. Reumatol Clin. 2016;12(6):323-326. Go to original source... Go to PubMed...
    22. Huang Q, Tao S-S, Zhang Y-J, et al. Serum resistin levels in patients with rheumatoid arthritis and systemic lupus erythematosus: a meta-analysis. Clin Rheumatol. 2015;34(10):1713-1720. Go to original source... Go to PubMed...
    23. Rho YH, Chung CP, Solus JF, et al. Adipocytokines, insulin resistance, and coronary atherosclerosis in rheumatoid arthritis. Arthritis Rheum. 2010;62(5):1259-1264. Go to original source... Go to PubMed...
    24. Alkady E, Ahmed H, Tag L, et al. [Serum and synovial adiponectin, resistin, and visfatin levels in rheumatoid arthritis patients. Relation to disease activity]. Z Rheumatol. 2011;70:602-608. Go to original source... Go to PubMed...
    25. Mohammad JA, Fathi ZH, Allwash TA. Assessment the effects of insulin on adiponectin, nitric oxide, myeloperoxidase and lipid profile in type 1 diabetic patients. Pharmacia. 2021;68(2). Go to original source...
    26. Verma S, Li SH, Wang CH, et al. Resistin promotes endothelial cell activation: further evidence of adipokine-endothelial interaction. Circulation. 2003;108(6):736-740. Go to original source... Go to PubMed...
    27. Kawanami D, Maemura K, Takeda N, et al. Direct reciprocal effects of resistin and adiponectin on vascular endothelial cells: a new insight into adipocytokine-endothelial cell interactions. Biochem Biophys Res Commun. 2004;314(2):415-419. Go to original source... Go to PubMed...
    28. Fathi ZH, Mohammad JA, Mohammed MH. Levels of Myeloperoxidase, Malondialdehyde and Lipid Profile in Type 2 Diabetic Patients on Metformin Versus Glibenclamide Therapy. Systematic Reviews in Pharmacy. 2020;11(11):1777-1782.
    29. Zhang Z, Xing X, Hensley G, et al. Resistin induces expression of proinflammatory cytokines and chemokines in human articular chondrocytes via transcription and messenger RNA stabilization. Arthritis Rheum. 2010;62(7):1993-2003. Go to original source... Go to PubMed...
    30. Tarkowski A, Bjersing J, Shestakov A, et al. Resistin competes with lipopolysaccharide for binding to toll-like receptor 4. J Cell Mol Med. 2010;14(6b):1419-1431. Go to original source... Go to PubMed...
    31. Williams DL, Ozment-Skelton T, Li C. Modulation of the phosphoinositide 3-kinase signaling pathway alters host response to sepsis, inflammation, and ischemia/reperfusion injury. Shock. 2006;25(5):432-439. Go to original source... Go to PubMed...
    32. Zwerina J, Redlich K, Schett G, et al. Pathogenesis of rheumatoid arthritis: targeting cytokines. Ann N Y Acad Sci. 2005;1051(1):716-729. Go to original source... Go to PubMed...
    33. Kaser S, Kaser A, Sandhofer A, et al. Resistin messenger-RNA expression is increased by proinflammatory cytokines in vitro. Biochem Biophys Res Commun. 2003;309(2):286-290. Go to original source... Go to PubMed...
    34. Reilly MP, Lehrke M, Wolfe ML, et al. Resistin is an inflammatory marker of atherosclerosis in humans. Circulation. 2005;111(7):932-939. Go to original source... Go to PubMed...
    35. Schäffler A, Ehling A, Neumann E, et al. Adipocytokines in synovial fluid. JAMA. 2003;290(13):1709-1710.
    36. Bokarewa M, Nagaev I, Dahlberg L, et al. Resistin, an adipokine with potent proinflammatory properties. J Immunol. 2005;174(9):5789-5795. Go to original source... Go to PubMed...
    37. Thommesen L, Stunes AK, Monjo M, et al. Expression and regulation of resistin in osteoblasts and osteoclasts indicate a role in bone metabolism. J Cell Biochem. 2006;99(3):824-834. Go to original source... Go to PubMed...
    38. Ichida Y, Hasegawa G, Fukui M, et al. Effect of atorvastatin on in vitro expression of resistin in adipocytes and monocytes/macrophages and effect of atorvastatin treatment on serum resistin levels in patients with type 2 diabetes. Pharmacol Ther. 2006;76:34-39. Go to original source... Go to PubMed...
    39. Hu WL, Qiao SB, Li JJ. Decreased C-reactive protein-induced resistin production in human monocytes by simvastatin. Cytokine. 2007;40(3):201-206. Go to original source... Go to PubMed...
    40. Shyu KG, Chua SK, Wang BW, et al. Mechanism of inhibitory effect of atorvastatin on resistin expression induced by tumor necrosis factor-alpha in macrophages. J Biomed Sci. 2009;16(1):50. Go to original source... Go to PubMed...
    41. Silswal N, Singh AK, Aruna B, et al. Human resistin stimulates the pro-inflammatory cytokines TNF-alpha and IL-12 in macrophages by NF-kappaB-dependent pathway. Biochem Biophys Res Commun. 2005;334(4):1092-1101. Go to original source... Go to PubMed...
    42. Gonzalez-Gay MA, Garcia-Unzueta MT, Gonzalez-Juanatey C, et al. Anti-TNF-alpha therapy modulates resistin in patients with rheumatoid arthritis. Clin Exp Rheumatol. 2008;26(2):311-316. Go to PubMed...
    43. Rea R, Donnelly R. Effects of metformin and oleic acid on adipocyte expression of resistin. Diabetes, Obesity and Metabolism. 2006;8(1):105-109. Go to original source... Go to PubMed...
    44. Fathi HF, Almulathanon YAA, Mohammad AJ. Therapeutic use of metformin in thyroid cancer. MMSL. 2022. Go to original source...
    45. Kassem E, Mahmoud L, Salah W. Study of Resistin and YKL-40 in rheumatoid arthritis. J Am Sci. 2010;6(10):1004-1012.
    46. Alkady EA, Ahmed HM, Tag L, et al. [Serum and synovial adiponectin, resistin, and visfatin levels in rheumatoid arthritis patients. Relation to disease activity]. Z Rheumatol. 2011;70(7):602-608. Go to original source... Go to PubMed...
    47. Yoshino T, Kusunoki N, Tanaka N, et al. Elevated serum levels of resistin, leptin, and adiponectin are associated with C-reactive protein and also other clinical conditions in rheumatoid arthritis. Intern Med. 2011;50(4):269-275. Go to original source... Go to PubMed...
    48. Hammad M, Nasef S, Musalam D, et al. Resistin, an adipokine , its relation to inflammation in Systemic Lupus Erythematosus and Rheumatoid Arthritis. Middle East J Intern Med. 2014;7(3):3-9. Go to original source...
    49. Senolt L, Housa D, Vernerová Z, et al. Resistin in rheumatoid arthritis synovial tissue, synovial fluid and serum. Ann Rheum Dis. 2007;66(4):458-463. Go to original source... Go to PubMed...
    50. Forsblad d'Elia H, Pullerits R, Carlsten H, et al. Resistin in serum is associated with higher levels of IL-1Ra in post-menopausal women with rheumatoid arthritis. Rheumatology (Oxford). 2008;47(7):1082-187. Go to original source... Go to PubMed...

    Return to the content